Influence of fluoxetine on the disposition kinetics of dolutegravir among people living with HIV with major depression in Nigeria
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
Emerging Global Leader
Project Information in NIH RePORTER
Influence of fluoxetine on the disposition kinetics of dolutegravir among people living with HIV with major depression in Nigeria
Principal Institution
College of Medicine, University of Ibadan
Principal Investigator(s) (PI)
Adedeji, Waheed Adeola
Project Contact Information
College of Medicine, University of Ibadan
Year(s) Awarded
2022–2027
Country
Nigeria
NIH Partners
NIMH
Project Description
The overall goal of this project is to provide advanced training to equip Dr. Adedeji Waheed A (a physician/scientist) with skills and competencies in clinical trials, population pharmacokinetics, pharmacokinetics/pharmacodynamics modeling, and pharmacogenomics. These skills will equip Dr. Adedeji to establish a research career in HIV clinical pharmacology and pharmacogenomics. The burden of HIV/AIDS is of global health concern, and Nigeria has the third largest burden of the disease in the world but lacks research capacity in HIV clinical pharmacology and pharmacogenomics.
Related World Regions / Countries
Related Global Health Research Topics